UnitedHealth Group (NYSE:UNH) had its price target boosted by Credit Suisse Group from $320.00 to $330.00 in a research report sent to investors on Wednesday, The Fly reports. They currently have an outperform rating on the healthcare conglomerate’s stock.
A number of other equities research analysts also recently weighed in on UNH. Citigroup dropped their target price on UnitedHealth Group from $299.00 to $286.00 and set a buy rating for the company in a research report on Wednesday, October 16th. Deutsche Bank started coverage on UnitedHealth Group in a report on Thursday, September 12th. They issued a hold rating and a $263.00 price objective for the company. Raymond James upped their price objective on UnitedHealth Group from $300.00 to $320.00 and gave the company a buy rating in a report on Thursday, December 5th. Wells Fargo & Co reiterated an overweight rating and issued a $335.00 price objective (up previously from $318.00) on shares of UnitedHealth Group in a report on Wednesday, December 11th. Finally, JPMorgan Chase & Co. upped their price objective on UnitedHealth Group from $276.00 to $361.00 and gave the company an overweight rating in a report on Friday, December 20th. Five equities research analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company’s stock. The company currently has an average rating of Buy and an average target price of $305.45.
UNH stock opened at $295.13 on Wednesday. The company has a market cap of $278.75 billion, a P/E ratio of 20.31, a PEG ratio of 1.40 and a beta of 0.65. UnitedHealth Group has a twelve month low of $208.07 and a twelve month high of $300.00. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.67. The business has a fifty day moving average of $287.12 and a 200-day moving average of $253.94.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $1.08 dividend. The ex-dividend date was Friday, December 6th. This represents a $4.32 dividend on an annualized basis and a yield of 1.46%. UnitedHealth Group’s payout ratio is 33.54%.
In other UnitedHealth Group news, EVP D Ellen Wilson sold 7,400 shares of the business’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $272.77, for a total value of $2,018,498.00. Also, CAO Thomas E. Roos sold 1,177 shares of the business’s stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $255.04, for a total value of $300,182.08. Following the completion of the transaction, the chief accounting officer now directly owns 21,687 shares of the company’s stock, valued at $5,531,052.48. The disclosure for this sale can be found here. Over the last three months, insiders sold 33,577 shares of company stock valued at $8,232,680. Insiders own 0.87% of the company’s stock.
Large investors have recently bought and sold shares of the business. Nuveen Asset Management LLC boosted its position in shares of UnitedHealth Group by 1,354.6% during the second quarter. Nuveen Asset Management LLC now owns 8,540,562 shares of the healthcare conglomerate’s stock worth $2,083,983,000 after buying an additional 7,953,416 shares during the period. Viking Global Investors LP boosted its position in shares of UnitedHealth Group by 28.6% during the second quarter. Viking Global Investors LP now owns 4,812,185 shares of the healthcare conglomerate’s stock worth $1,174,221,000 after buying an additional 1,071,149 shares during the period. Longview Partners Guernsey LTD boosted its position in shares of UnitedHealth Group by 9.9% during the second quarter. Longview Partners Guernsey LTD now owns 3,752,630 shares of the healthcare conglomerate’s stock worth $915,679,000 after buying an additional 338,097 shares during the period. California Public Employees Retirement System boosted its position in shares of UnitedHealth Group by 15.0% during the third quarter. California Public Employees Retirement System now owns 3,356,394 shares of the healthcare conglomerate’s stock worth $729,412,000 after buying an additional 437,189 shares during the period. Finally, Boston Partners boosted its position in shares of UnitedHealth Group by 160.8% during the second quarter. Boston Partners now owns 2,550,998 shares of the healthcare conglomerate’s stock worth $622,942,000 after buying an additional 1,572,711 shares during the period. 85.44% of the stock is owned by hedge funds and other institutional investors.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Compound Annual Growth Rate (CAGR)
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.